Protalix BioTherapeutics PE Ratio 1970-1969 | PLX
Current and historical p/e ratio for Protalix BioTherapeutics (PLX) from 1970 to 1969. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Protalix BioTherapeutics PE ratio as of September 23, 2021 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
|Protalix BioTherapeutics PE Ratio Historical Data
||TTM Net EPS
||Medical - Biomedical and Genetics
Protalix BioTherapeutics Inc. is a biopharmaceutical company. It is focused on the development and commercialization of recombinant therapeutic proteins. The company's product pipeline includes ProCellEx(R). Protalix BioTherapeutics Inc. is based in CARMIEL, Israel.